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Human induced pluripotent stem cells (HiPSCs) ap-
pear to be highly similar to human embryonic stem
cells (HESCs). Using two genetic lineage-tracing
systems, we demonstrate the generation of iPSC
lines fromhumanpancreatic islet beta cells. These re-
programmed cells acquired markers of pluripotent
cells and differentiated into the three embryonic
germ layers. However, the beta cell-derived iPSCs
(BiPSCs) maintained open chromatin structure at
key beta-cell genes, together with a unique DNA
methylation signature that distinguishes them from
other PSCs. BiPSCs also demonstrated an increased
ability to differentiate into insulin-producing cells
both in vitro and in vivo, compared with ESCs and
isogenic non-beta iPSCs. Our results suggest that
the epigenetic memory may predispose BiPSCs to
differentiate more readily into insulin producing cells.
These findings demonstrate that HiPSC phenotype
maybe influencedby their cells of origin, and suggest
that their skewed differentiation potential may be
advantageous for cell replacement therapy.
Human embryonic stem cells (HESCs) are capable of unlimited
proliferation in vitro while maintaining their potential to differen-
tiate into cells from the three embryonic germ layers (Itskovitz-
Eldor et al., 2000; Thomson et al., 1998). Human induced plurip-
otent stem cells (HiPSCs) have been generated from human
somatic fibroblasts (Lowry et al., 2008; Park et al., 2008; Takaha-
shi et al., 2007; Yu et al., 2007) and other human cell types,
including CD34+ cells from peripheral blood (Loh et al., 2009),
keratinocytes (Aasen et al., 2008), and neural stem cells (Kim
et al., 2009). Although HiPSCs were shown to be similar to
HESCs, as judged by expression of pluripotency genes and their
ability to generate embryoid bodies (EBs) and teratomas,
mounting evidence suggested that iPSCs differed from ESCs
in gene expression profiles (Chin et al., 2009), persistence of
donor-cell gene expression (Ghosh et al., 2010; Marchetto
et al., 2009), differentiation abilities (Feng et al., 2010; Hu et al.,
2010), genetic stability (Mayshar et al., 2010), stability ofimprinted gene expression (Pick et al., 2009), and disease
modeling (Urbach et al., 2010). Recently, it has been shown
that following the reprogramming of mouse iPSCs, an epigenetic
memory is inherited from the parental cell (Kim et al., 2010; Polo
et al., 2010). Some emerging works also show a unique DNA
methylation signature that is inherited from a parental human
cell following reprogramming (Doi et al., 2009; Lister et al.,
2011; Ohi et al., 2011).
Differentiation of HESCs and HiPSCs into insulin-producing
cells represents an attractive approach for cell replacement
therapy of diabetes (McKnight et al., 2010; Kroon et al., 2008).
We wished to evaluate the differentiation potential of iPSCs
derived from human beta cells. To this end, we utilized two
recently developed genetic lineage-tracing approaches (Russ
et al., 2008, 2009) (Figure 1A) to specifically label human beta
cells within cultures of pancreatic islet cells containing multiple
cell types (Figure 1B). Both labeling approaches are based on
the Cre/lox system, routinely used in transgenic animals (Dor
et al., 2004). In our procedure, the human islet cells are infected
with a mixture of two lentiviral vectors. In the first system, Cre
recombinase is expressed under control of the insulin promoter,
while the second system is improved by fusing Cre recombinase
to the estrogen receptor (ER), rendering DNA recombination
inducible by tamoxifen. Since the insulin promoter is expressed
only in beta cells, the Cre enzyme excises the floxed DNA region
of the reporter constructs, thereby activating constitutive GFP
expression specifically in beta cells (Figures 1A and 1B). The
genetic label is stable in all beta cell-derived (BCD) progeny,
making it possible to determine the cellular origin of reprog-
rammed cells derived from beta cells. BCD cells undergo dedif-
ferentiation and epithelial to mesenchymal transition following
their growth in culture, as was described previously (Russ
et al., 2008, 2009). Human islet cell cultures containing about
20% lineage-traced BCD cells following 3–9 weeks in culture
were transduced with retroviral vectors encoding the four
pluripotency-inducing factors OCT4, SOX2, KLF4, and cMYC.
ES-like colonies were detected 3–6 weeks later with an
extremely low efficiency (0.0001%) (Figure S1A). A number of
these colonies were isolated and expanded for further analysis.
To demonstrate the beta cell origin of the iPSCs, DNA PCR anal-
ysis of the integrated recombined reporter cassettes was per-
formed. Out of dozens of iPSC lines established from four islet
donors, four cell lines containing only the shorter PCR product
corresponding to the recombined reporter gene (Figure 1C)Cell Stem Cell 9, 17–23, July 8, 2011 ª2011 Elsevier Inc. 17
Figure 1. Genetic Labeling of Human Beta Cells, Generation of BiPSC Clones, and Epigenetic Memory in BiPSCs
(A) Schematic representation of two dual lentiviral lineage-tracing systems for specific labeling of human beta cells.
(B) Representative images of GFP+BCDcells at passage3 generatedwith each labeling system.Note that cells labeledwith system2were enriched by FACS sorting.
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obtain four isogenic non-beta pancreatic iPSC (PiPSC) lines
derived from non-beta cells of the same donors, as judged by
the absence of a recombined reporter gene (Figure 1C and Fig-
ure S1B) (in spite of the presence of DNA of theCre gene from the
two labeling vectors). When foreskin fibroblasts were infected
with the genetic lineage-tracing system, no DNA recombination
of the reporter vector or GFP expression was observed, further
indicating the specificity of the labeling system (Figures S1C
and S1D). Transduction of the lineage-traced fibroblasts with
the pluripotency-inducing factors resulted in establishment of
iPSC colonies at a normal efficiency. However, no GFP expres-
sion or recombination event could be detected following reprog-
ramming, indicating that the labeling system was not affected by
the reprogramming process (Figures S1C and S1D).
The BiPSC lines contained all four retroviral transgenes, as
judged by genomic DNA PCR analyses (Figure S1E). The rela-
tively low efficiency of human BCD cell reprogramming is in
accordance with a report describing low reprogramming rate
of mouse beta cells (Stadtfeld et al., 2008). This low efficiency,
compared to that of fibroblasts (0.0025%), may be attributed
to a more differentiated state of the BCD cells, which has been
shown to affect the efficiency of reprogramming (Eminli et al.,
2009). BiPSC lines showed a typical ES-like morphology (Fig-
ure S1A) and could be maintained for at least 30 passages. We
have thoroughly characterized the BiPSC clones by the most
stringent criteria for pluripotency of HiPSCs (Daley et al., 2009;
Maherali and Hochedlinger, 2008). Thus, BiPSCs were positive
for many pluripotency markers at both RNA and protein levels,
silenced the retroviral transgenes, and maintained a normal
diploid karyotype (Figures S1F–S1I). A recent work (Chan et al.,
2009) suggested that bona fide iPSCs can be distinguished
from partially reprogrammed cells by the expression of REX1,
DNMT3B, and Tra-1-60. BiPSCs express these markers in
comparable levels to other HiPSCs and HESCs, confirming their
full reprogramming (Figures S1G, S1H, and S2A). In addition, mi-
croarray analysis of gene expression showed that BiPSCs were
globally similar to HiPSCs or HESCs, as shown by scatter plot
and hierarchical cluster analyses, while differing markedly from
the parental BCD cells (Figures S2B and S2C). Of note, the linear
correlation coefficient between BiPS1 and ESCs was 0.94,(C) PCR analysis of DNA from lineage-traced islet cells containing labeled BCD c
each reporter vector. Both the original and the recombined DNA fragments are see
four BiPSC clones show only the recombined DNA fragment (lower band).
(D) qPCR analysis of INSULIN, PDX1, and MAFA expression (mean ± SE) in islet
(E) Chromatin immunoprecipitation (ChIP) analysis of histone H3-tail acetylation i
cells after 7–11 weeks in culture. Note that the unlabeled fraction contains unlab
primers recognizing the promoter regions of INSULIN (275), PDX1, or MAFA. V
(F and G) ChIP analysis of histone H3-tail acetylation in islet cells, BCD cells, BiPS
performed on bound and input DNA with primers recognizing the insulin locus a
MAFA promoters. Values are mean ± SE (n = 3–4 cell lines) (Table S1) and are n
(H) Hierarchical clustering of BiPSCs, iPSCs, ESCs, BCD cells, and fibroblast ce
(I) DNA methylation analysis of specific genes in somatic cells and PSCs.
HumanMethylation27 BeadChiP arrays. Shown are the following: I, pluripotenc
correlation with upregulation in their gene expression; II, somatic-related gen
downregulation in their gene expression; and III, islet-expressed genes that are h
other cell types. Values are mean ± SE.
(J) Pyrosequencing analysis of DNA methylation at the PDX1 promoter on 13 CpG
versus iPSCs. The color bar label ‘‘High’’ refers to >68% methylation, while ‘‘Low
See also Figures S1 and S2.similar to the correlation coefficient between two different ESC
lines (R2 = 0.94), and different from the correlation coefficient
between BiPS1 and its original somatic cell lines (R2 = 0.65).
BiPSCs gave rise to differentiated cells from the three embryonic
germ layers in vitro, as judged by EB formation assay, and
in vivo, as evidenced by teratoma formation assay (Figures
S2D–S2F). Taken together, these results demonstrate that
BiPSCs are truly reprogrammed PSCs.
Epigenetic memory of active gene transcription or persistent
chromatin structure has been suggested to explain the clinical
anomalies observed in cloned animals generated by somatic
cell nuclear transfer (Gao et al., 2003; Ng and Gurdon, 2005,
2008; Santos et al., 2003; Wee et al., 2006). This epigenetic
memory was shown to manifest in donor cell-specific gene tran-
scription patterns in most cells of the cloned animal (Gao et al.,
2003; Ng and Gurdon, 2005), or in histone modifications persist-
ing from the donor cell (Ng and Gurdon, 2008; Santos et al.,
2003; Wee et al., 2006). We thus evaluated the levels of histone
H3 acetylation, a hallmark of open chromatin structure, by chro-
matin immunoprecipitation (ChIP) in fresh human islets, BCD
cells, BiPSCs, PiPSCs, iPSCs derived from fibroblasts, and
ESCs (see Table S1 for cell lines used in this study, and the rele-
vant passage number). Although BCD cells do not express
INSULIN or the beta-cell transcription factors PDX1 and MAFA
(Figure 1D), they maintain a partially open chromatin structure
on the promoter regions of these genes, as judged by histone
H3 acetylation (Figure 1E). This epigenetic imprint was also
maintained in the INSULIN and PDX1 gene promoters in three
BiPSC lines in levels comparable to those of BCD cells, while
not detected in PiPSCs, iPSCs, or ESCs of similar passage
numbers (Figure 1F and Table S1). In contrast, the histone H3
on the MAFA promoter underwent deacetylation during reprog-
ramming of BCD cells into BiPSCs (Figure 1G). To determine
whether a similar preservation of epigenetic memory occurred
at the DNA methylation level, we utilized Illumina’s Infinium
HumanMethylation27 BeadChiP arrays to compare the DNA
methylation patterns of BCD cells, BiPSCs, fibroblasts, iPSCs,
and ESCs. Hierarchical clustering revealed a unique DNA meth-
ylation pattern in BiPSCs that considerably distinguished them
from BCD cells, and also separated them from other PSCs (Fig-
ure 1H). A closer look at the DNA methylation status of specificells, BiPSCs, and PiPSCs, using primers spanning the floxed DNA fragment of
n in the parental cells, while the four PiPSCs show the original fragment, and the
cells, BCD cells, and undifferentiated BiPSCs, PiPSCs, iPSCs, and ESCs.
n fresh islet cells in comparison to sorted GFP+ BCD cells and nonlabeled islet
eled BCD cells. qPCR analysis was performed on bound and input DNA with
alues are mean ± SD (n = 3–5 donors) and are normalized to CRYSTALLIN.
Cs, PiPSCs, iPSCs, and ESCs at promoters of key beta-cell genes. qPCR was
t positions 275, +5, and +1318 from the transcription start site, and PDX1 or
ormalized to CRYSTALLIN. n.s., not significant.
lls using Illumina’s Infinium HumanMethylation27 BeadChiP arrays.
The status of DNA methylation was determined using Illumina’s Infinium
y-related genes that underwent demethylation following reprogramming, in
es that underwent methylation following reprogramming, in correlation with
ypomethylated in BCD cells and remain hypomethylated in BiPSCs, relative to
island positions in BiPSCs, compared with that in iPSCs. *p < 0.05 in BiPSCs
’’ indicates no detectable methylation at the respective position.
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Figure 2. Skewed Differentiation of BiPSCs into Insulin-Producing Cells
(A) Expression levels of INSULIN, PDX1, and FOXA2 transcripts in day 20 EBs analyzed by qPCR. Data represent mean of four BiPSC lines, three PiPSC lines, five
iPSC lines, and three ESCl lines (Table S1). Values are mean ± SE, compared to EBs from ESCs (RQ = 1).
(B) qPCR analysis of INSULIN, PDX1, and FOXA2 transcripts in day 30 teratomas derived from BiPSCs, PiPSCs, iPSCs, and ESCs. Data represent biological
repeats of three BiPSC lines, three PiPSC lines, four iPSC lines, and three ESC lines (Table S1). Values aremean ± SE, compared to teratomas from ESCs (RQ= 1).
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demethylation during reprogramming, while somatic-specific
genes became more methylated (Figure 1I). We could also iden-
tify genes expressed in human islet cells that were hypomethy-
lated in BCD cells, and remained hypomethylated in BiPSCs,
while being methylated in fibroblasts, fibroblast-derived iPSCs,
and ESCs (Figure 1I). These findings support the retention of
an epigenetic memory in BiPSCs. Finally, methylation of the
PDX1 promoter was compared in BiPSCs and iPSCs by pyrose-
quencing analysis. BiPSCs exhibited significantly lower DNA
methylation levels, characteristic of transcribed genes, in 8/13
positions analyzed, compared with iPSCs derived from fibro-
blasts cells (Figure 1J), and PiPSCs derived from non-beta
pancreatic cells, which exhibited about 25% higher DNAmethyl-
ation levels than BiPSCs. The higher DNA methylation levels in
the PDX1 promoter in iPSCs compared to those of BiPSCs
may reflect a variable epigenetic memory in iPSCs derived
from fibroblasts.
To address the possibility that the observed epigenetic
memory rendered BiPSCs permissive to skewed differentiation
into cells of the endodermal lineage, and possibly into insulin-
producing cells, expression of beta-cell genes was analyzed in
EBs and teratomas derived from BiPSC lines, in comparison to
that in PiPSCs, iPSCs, and ESCs. Multiple differentiation exper-
iments performed at similar passage numbers (Table S1)
showed that INSULIN, PDX1, and FOXA2 mRNA expression
was significantly higher in both EBs and teratomas derived
from BiPSCs, when compared to that in EBs and teratomas
derived from PiPSCs, iPSCs, and ESCs (Figures 2A and 2B).
Although both EBs and teratomas are composed of many
different cell types, which may hinder the conclusions drawn
from their analysis, our data does show preferred differentiation
into endoderm in these complex differentiated structures. No
significant differences were noted between the four BiPSC lines
studied. Moreover, C-peptide protein could only be detected in
EBs derived from BiPSCs (Figure 2C). However, C-peptide
protein was not detectable in teratomas derived from either
BiPSCs or ESCs (data not shown). In contrast to PDX1, MAFA
expression in EBs from BiPSCs was not significantly different
from that in iPSCs and ESCs (data not shown), in accordance
with the lack of epigenetic memory in the MAFA promoter (Fig-
ure 1G). Unlike these beta-cell genes, no significant differences
were found in genes of ectodermal, mesodermal, and endo-
dermal tissues (data not shown).
Next we utilized a protocol for induced differentiation of
HESCs into pancreatic endocrine progenitors (Kroon et al.,
2008). BiPSCs could be differentiated into endocrine progenitor
cells expressing the beta-cell transcription factors PDX1,
NKX6.1, FOXA2, and ISL1 by day 12 (Figures S2G and S2H).(C) Immunofluorescence analysis of insulin and C-peptide in islet cells and day 2
specific. Nuclei were stained blue with DAPI. Bar = 20 mm. Only a small number
none were seen in EBs derived from ESCs.
(D–F) Differentiation induced with the protocol of Kroon et al. (2008). (D) Serum
with ESC- or BiPSC-derived endocrine progenitors at indicated time points post
(n = 8 mice in each group). The assay sensitivity is 1.5 pmol/L. (E) qPCR ana
in comparison with ESC-derived grafts. DCt is normalized to GAPDH. Values ar
C-peptide in a BiPSC-derived graft removed 6 weeks posttransplantation. Nucle
See also Figure S2.Previously, it was shown that pancreatic endocrine progenitors
can further mature into beta-like cells when grafted into mice
(Kroon et al., 2008). We thus transplanted 2.5–4 3 106 BiPSC-
or ESC-derived pancreatic endocrine progenitors under the
renal capsule of SCIDmice andmeasured serum levels of human
C-peptide following glucose challenge (Russ and Efrat, in press).
Transplantation of BiPSC-derived pancreatic endocrine progen-
itor cells resulted in detectable serum levels of human C-peptide
as early as 3 weeks posttransplantation, while no human
C-peptide was detected in mice transplanted with human
ESC-derived pancreatic endocrine progenitors during the first
4 weeks following transplantation (Figure 2D). Human C-peptide
was detected in the ESC-derived progenitors 6 weeks after
transplantation; however, these C-peptide levels were an order
of magnitude lower than those in BiPSC-derived grafts. The
levels of C-peptide detected in BiPSC-derived grafts after
3–4 weeks suggest that BiPSC-derived endocrine progenitor
cells matured faster in vivo compared to ESC-derived endocrine
progenitor cells. Graft analysis 6–7 weeks posttransplantation
revealed insulin mRNA expression in all three BiPSC-derived
grafts examined (Figure 2E). C-peptide staining was detected
in 2/7 BiPSC-derived grafts at this time point (Figure 2F). These
grafts also expressed glucagon, somatostatin, pancreatic poly-
peptide, and amylase transcripts (Figure 2E). In contrast, ESC-
derived grafts expressed detectable levels of the other four
pancreatic transcripts analyzed, but not insulin (Figure 2E).
The first reports of generation of HiPSCs focused primarily on
their similarity to HESCs, although recent works have addressed
the differences between the two PSC types (Chin et al., 2009; Doi
et al., 2009; Feng et al., 2010; Ghosh et al., 2010; Hu et al., 2010;
Kim et al., 2010; Lister et al., 2011; Marchetto et al., 2009; May-
shar et al., 2010; Ohi et al., 2011; Pick et al., 2009; Polo et al.,
2010; Urbach et al., 2010). Here we report the reprogramming
to pluripotency of human pancreatic beta cells, and demonstrate
the utility of a lineage-tracing system in primary human cells for
monitoring the origin of the reprogrammed cells. Our findings
document the existence of an epigeneticmemory in cells derived
from human beta cells during their expansion in vitro. This
memory is maintained during reprogramming into iPSCs in
most of the markers analyzed. The epigenetic differences
between BiPSCs and iPSCs/ESCs may be responsible for differ-
ences in their differentiation capabilities. BiPSCs may have
a higher propensity to express PDX1 and insulin upon differenti-
ation due to the relatively open chromatin structure of these loci.
This skewed differentiation manifests as their increased capacity
for spontaneous differentiation into insulin-producing cells.
Our results prescribe caution in utilizing HiPSCs derived from
different cell types for disease modeling or for the study of early
developmental events, since the cells may differ according to0 EBs derived from ESCs and BiPSCs. The C-peptide antibody used is human
of insulin-positive areas were detected in EBs derived from BiPSCs; however,
human C-peptide levels following glucose challenge in mice transplanted
transplantation, compared with those of sham controls. Values are mean ± SE
lysis of pancreatic gene expression in BiPS1 and BiPS2 cell-derived grafts,
e mean ± SE (n = 3 mice in each group). (F) Immunofluorescence analysis of
i were stained blue with DAPI. Bar = 20 mm.
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differences may be harnessed for generation of PSCs with a
skewed ability to differentiate into a specific cell type. This
approach may prove useful in the generation of differentiated
cell types that are currently hard to produce from existing
PSCs for the treatment of human diseases.ACCESSION NUMBERS
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